Id |
Subject |
Object |
Predicate |
Lexical cue |
T25 |
0-173 |
Sentence |
denotes |
IL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. |
T26 |
174-309 |
Sentence |
denotes |
IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. |
T27 |
310-482 |
Sentence |
denotes |
IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. |
T28 |
483-666 |
Sentence |
denotes |
IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. |
T29 |
667-776 |
Sentence |
denotes |
Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. |
T30 |
777-996 |
Sentence |
denotes |
In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. |
T31 |
997-1234 |
Sentence |
denotes |
At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. |
T32 |
1235-1437 |
Sentence |
denotes |
IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. |
T33 |
1438-1527 |
Sentence |
denotes |
In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. |
T34 |
1528-1561 |
Sentence |
denotes |
CCR=C-C motif chemokine receptor. |
T35 |
1562-1593 |
Sentence |
denotes |
CCL=C-C motif chemokine ligand. |
T36 |
1594-1628 |
Sentence |
denotes |
CXCL=C-X-C motif chemokine ligand. |
T37 |
1629-1659 |
Sentence |
denotes |
CXCR=C-X-C chemokine receptor. |
T38 |
1660-1686 |
Sentence |
denotes |
Foxp=forkhead box protein. |
T39 |
1687-1712 |
Sentence |
denotes |
GATA=GATA-binding factor. |
T40 |
1713-1769 |
Sentence |
denotes |
GM-CSF=granulocyte-macrophage colony-stimulating factor. |
T41 |
1770-1785 |
Sentence |
denotes |
IL=interleukin. |
T42 |
1786-1819 |
Sentence |
denotes |
ILC2=type 2 innate lymphoid cell. |
T43 |
1820-1875 |
Sentence |
denotes |
MyD88=myeloid differentiation primary response protein. |
T44 |
1876-1905 |
Sentence |
denotes |
NF-κB=nuclear factor-kappa B. |
T45 |
1906-1958 |
Sentence |
denotes |
NLRP=NACHT, LRR, and PYD domains-containing protein. |
T46 |
1959-1990 |
Sentence |
denotes |
PU.1=transcription factor PU.1. |
T47 |
1991-2023 |
Sentence |
denotes |
RORC=nuclear receptor ROR-gamma. |
T48 |
2024-2041 |
Sentence |
denotes |
ST2=ST2 receptor. |
T49 |
2042-2093 |
Sentence |
denotes |
STAT=signal transducer and transcription activator. |
T50 |
2094-2125 |
Sentence |
denotes |
TGF=transforming growth factor. |
T51 |
2126-2138 |
Sentence |
denotes |
Th=T-helper. |
T52 |
2139-2163 |
Sentence |
denotes |
TLR=toll-like receptors. |
T53 |
2164-2187 |
Sentence |
denotes |
Treg=regulatory T cell. |